Robert F. Apple, President & CEO at ANTARES PHARMA, INC. (ATRS), sold 631,636 shares at $5.00 ($3.1M) on 2021-02-18, disclosed to the SEC on 2021-02-19.
Seasonal sale ($3.1M) by President & CEO — this insider has traded ATRS in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.73 | 116,313 | $550K | 17.6% |
| 2 | $4.75 | 5,519 | $26K | 0.8% |
| 3 | $5.00 | 232,156 | $1.2M | 37.1% |
| 4 | $5.00 | 241,960 | $1.2M | 38.7% |
| 5 | $5.01 | 17,844 | $89K | 2.9% |
| 6 | $5.01 | 17,844 |
| $89K |
| 2.9% |
| Total | $4.95 avg | 631,636 | $3.1M | 100% |
| Filing → |
| ATRS | SELL | 2018-08-23 | $161K | — | Filing → |
| ATRS | SELL | 2017-04-05 | $120K | — | Filing → |
| ATRS | BUY | 2016-03-18 | $43K | — | Filing → |